Amdocs Net Worth

Amdocs Net Worth Analysis

Amdocs Target Price Consensus

Amdocs Target Price Projection

Amdocs' current and average target prices are 87.85 and 102.12, respectively. The current price of Amdocs is the price at which Amdocs is currently trading. On the other hand, Amdocs' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Amdocs and the information provided on this page.

Know Amdocs' Top Institutional Investors

Note, although Amdocs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Amdocs' market capitalization trends

The company currently falls under 'Mid-Cap' category with a total capitalization of 9.77 B.

Project Amdocs' profitablity

The company has Net Profit Margin of 0.11 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Amdocs' management efficiency

Amdocs has Return on Asset of 0.0783 % which means that on every $100 spent on assets, it made $0.0783 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1535 %, implying that it generated $0.1535 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.10 in 2025. Return On Capital Employed is likely to drop to 0.14 in 2025. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 676.1 M in 2025, whereas Total Assets are likely to drop slightly above 4.6 B in 2025.

Amdocs Corporate Filings

Amdocs time-series forecasting models is one of many Amdocs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amdocs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Amdocs Earnings Estimation Breakdown

The calculation of Amdocs' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Amdocs is estimated to be 1.900675 with the future projection ranging from a low of 1.865 to a high of 1.9375. Please be aware that this consensus of annual earnings estimates for Amdocs is based on EPS before non-recurring items and includes expenses related to employee stock options.

Amdocs Earnings Projection Consensus

Amdocs Earnings History

Earnings estimate consensus by Amdocs analysts from Wall Street is used by the market to judge Amdocs' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Amdocs' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods. Retained Earnings is likely to rise to about 8.2 B in 2025, whereas Earnings Yield is likely to drop 0.04 in 2025. Common Stock Shares Outstanding is likely to rise to about 142.4 M in 2025, whereas Net Income Applicable To Common Shares is likely to drop slightly above 396.4 M in 2025.

Hype Prediction Low Estimated High 87.31 88.41 89.51 Details

Intrinsic Valuation Low Real High 74.07 75.17 97.25 Details

Naive Forecast Low Next High 88.04 89.15 90.25 Details

7 Analysts Consensus Low Target High 92.93 102.12 113.35 Details

Note that many institutional investors and large investment bankers can move markets due to the volume of Amdocs assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Amdocs. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Amdocs' stock price in the short term.

Amdocs Earnings per Share Projection vs Actual

Actual Earning per Share of Amdocs refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Amdocs predict the company's earnings will be in the future. The higher the earnings per share of Amdocs, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Amdocs Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Amdocs, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Amdocs should always be considered in relation to other companies to make a more educated investment decision.

Amdocs Quarterly Analyst Estimates and Surprise Metrics

Amdocs Corporate Management

Additional Tools for Amdocs Stock Analysis